The article discusses the author's experience with hair loss while using the GLP1 weight-loss medication Mounjaro. The author describes losing significant amounts of hair, fearing baldness, and consulting a trichologist who identified the issue as telogen effluvium (TE), a known side effect of GLP1 medications. The author eventually switched to Wegovy due to concerns about continued hair loss. While the author highlights the health benefits of weight loss, they emphasize the negative impact of hair thinning and the emotional distress caused by the condition.
Bias read (Center): The article presents a personal account of hair loss linked to a specific medication, focusing on individual health experiences rather than advocating for or against the medication itself. It includes medical information from a trichologist and references scientific studies, maintaining a balanced,



